Abatacept

Common brands: Orencia, Methotrexate, Rasuvo, Otrexup, Trexall

Top reporter: E.R. Squibb & Sons, L.L.C.

Selective T Cell Costimulation Modulator [EPC]Folate Analog Metabolic Inhibitor [EPC]Tumor Necrosis Factor Blocker [EPC]Corticosteroid [EPC]Interleukin-6 Receptor Antagonist [EPC]
135,352
Total Reports
54,545
Serious Reports
8,943
Death Reports
30
Reported Reactions
Death Report Ratio: High (6.61%)

Patient Demographics

Male
18,234
Female
103,695

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Abatacept.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 38,811
10.5%
2 RHEUMATOID ARTHRITIS 23,924
6.4%
3 PAIN 21,580
5.8%
4 ARTHRALGIA 20,718
5.6%
5 JOINT SWELLING 20,106
5.4%
6 FATIGUE 14,326
3.9%
7 CONTRAINDICATED PRODUCT ADMINISTERED 13,901
3.7%
8 RASH 13,127
3.5%
9 DRUG INTOLERANCE 13,109
3.5%
10 OFF LABEL USE 11,951
3.2%
11 ARTHROPATHY 11,669
3.1%
12 ALOPECIA 10,624
2.9%
13 SYNOVITIS 10,235
2.8%
14 ABDOMINAL DISCOMFORT 10,104
2.7%
15 TREATMENT FAILURE 9,809
2.6%
16 SWELLING 9,686
2.6%
17 HYPERSENSITIVITY 9,533
2.6%
18 HEADACHE 9,383
2.5%
19 SYSTEMIC LUPUS ERYTHEMATOSUS 9,318
2.5%
20 CONDITION AGGRAVATED 9,026
2.4%
21 PEMPHIGUS 8,731
2.4%
22 DRUG HYPERSENSITIVITY 8,405
2.3%
23 INFECTION 8,388
2.3%
24 PERIPHERAL SWELLING 8,171
2.2%
25 NAUSEA 8,159
2.2%
26 GLOSSODYNIA 8,085
2.2%
27 HEPATIC ENZYME INCREASED 7,820
2.1%
28 HAND DEFORMITY 7,652
2.1%
29 THERAPEUTIC PRODUCT EFFECT DECREASED 7,640
2.1%
30 INFUSION RELATED REACTION 7,263
2.0%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.